B. J. Willett

The paper examines SARS-CoV-2 seroprevalence and cross-variant antibody neutralization in UK domestic cats, finding a 3.2% overall seroprevalence with variant-specific responses correlating with human circulation patterns.

This study compares the antigenic properties of SARS-CoV-2 Omicron variants BA.4 and BA.5 with BA.1, BA.2, and vaccine-induced antibodies, finding they are antigenically distinct and show enhanced neutralisation breadth after breakthrough infection.

The paper reports a previously unreported RVF outbreak in peri-urban dairy cattle in northern Tanzania, identifying 14 abortions and viral shedding in milk.

This paper develops potent neutralizing nanobodies against SARS-CoV-2 variants, including B.1.351, to address reduced vaccine efficacy.

This study shows that in vitro evolution of SARS-CoV-2 under remdesivir selects for resistant mutations, but these mutations do not spread widely in global variants.

This study reports two cases of SARS-CoV-2 infection in UK cats linked to human-to-cat transmission, showing mild to severe respiratory disease and genetic variation in the viral genome.

The paper develops a rapid, low-volume rabies virus neutralizing antibody test for low-containment labs, showing moderate sensitivity and high specificity.

This study estimates age-specific force of infection for Peste des petits ruminants virus in Tanzanian livestock using seroprevalence data, finding weak age heterogeneity and suggesting management systems, not age, should guide control efforts.